ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Nektar, Pfizer Announce Oncology Clinical Collaboration
November 10, 2018Nektar Therapeutics has entered into an oncology clinical collaboration with Pfizer to evaluate several combination regimens in multiple cancer settings, including metastatic castration-resistant prostate cancer (mCRPC) and squamous cell carcinoma of the -
Nektar, Pfizer Announce Oncology Clinical Collaboration
November 10, 2018Nektar Therapeutics has entered into an oncology clinical collaboration with Pfizer to evaluate several combination regimens in multiple cancer settings, including metastatic castration-resistant prostate cancer (mCRPC) and squamous cell carcinoma of the -
Could Nektar Therapeutics Be Worth More?
March 24, 2017Nektar Therapeutics is an intriguing commercial-stage biotech company that's just reported positive late-stage trial results for its pain-busting drug NKTR-181. However, shares have jumped on the news, and the company's market cap has swollen to more than
Pharma Sources Insight January 2025
